<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Mon, 06 Oct 2025 10:47:55 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday</title><link>https://www.benzinga.com/news/25/10/48039862/this-commerce-bancshares-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/06/Two-Diverse-Crypto-Traders-Brokers-Stock_0.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Mon, 06 Oct 2025 13:53:04 GMT</pubDate></item><item><title>AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy</title><link>https://www.benzinga.com/markets/large-cap/25/10/48039835/astrazeneca-daiichi-sankyo-partnered-breast-cancer-drug-shows-survival-benefit-over-chemotherap</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/06/Astrazeneca-U-s--Headquarters-In-Wilming.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>AstraZeneca and Daiichi Sankyo's Datroway improved survival outcomes over chemotherapy in advanced triple-negative breast cancer patients. read more</description><pubDate>Mon, 06 Oct 2025 13:50:29 GMT</pubDate></item><item><title>How To Trade SPY, Top Tech Stocks Using Technical Analysis</title><link>https://www.benzinga.com/Opinion/25/10/48039825/how-to-trade-spy-top-tech-stocks-using-technical-analysis-35</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>read more</description><pubDate>Mon, 06 Oct 2025 13:49:34 GMT</pubDate></item><item><title>Cramer Warns On One Chip Stock, Says Broadcom Is The Better Bet</title><link>https://www.benzinga.com/trading-ideas/long-ideas/25/10/48039808/cramer-warns-on-one-chip-stock-says-broadcom-is-the-better-bet</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/06/Jim-Cramer.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Jim Cramer recommends caution with Ambiq Micro (AMBQ) and suggests Broadcom (AVGO). He dislikes Albertsons (ACI) and advises selling some Dillard's (D...</description><pubDate>Mon, 06 Oct 2025 13:48:55 GMT</pubDate></item><item><title>Celanese Stock: What Sparked The Collapse?</title><link>https://www.benzinga.com/Opinion/25/10/48039707/celanese-stock-what-sparked-the-collapse</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/06/Celanese-Cakra-Breakdown-Adhishthana.png?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Adhishthana.com analysis reveals why Celanese stock has collapsed nearly 80% since 2024, and what lies ahead for the stock read more</description><pubDate>Mon, 06 Oct 2025 13:45:13 GMT</pubDate></item></channel></rss>